SI9520112A - Aminokislinske nukleinske kisline - Google Patents

Aminokislinske nukleinske kisline Download PDF

Info

Publication number
SI9520112A
SI9520112A SI9520112A SI9520112A SI9520112A SI 9520112 A SI9520112 A SI 9520112A SI 9520112 A SI9520112 A SI 9520112A SI 9520112 A SI9520112 A SI 9520112A SI 9520112 A SI9520112 A SI 9520112A
Authority
SI
Slovenia
Prior art keywords
lower alkyl
oligomers
mmol
bonds
evaporated
Prior art date
Application number
SI9520112A
Other languages
English (en)
Slovenian (sl)
Inventor
Kandasamy Ramasamy
Guangyi Wang
Wilfried Seifert
Original Assignee
Icn Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icn Pharmaceuticals filed Critical Icn Pharmaceuticals
Publication of SI9520112A publication Critical patent/SI9520112A/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI9520112A 1994-11-02 1995-11-02 Aminokislinske nukleinske kisline SI9520112A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33389594A 1994-11-02 1994-11-02
PCT/US1995/014599 WO1996014330A1 (en) 1994-11-02 1995-11-02 Amino acid nucleic acids

Publications (1)

Publication Number Publication Date
SI9520112A true SI9520112A (sl) 1998-08-31

Family

ID=23304698

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9520112A SI9520112A (sl) 1994-11-02 1995-11-02 Aminokislinske nukleinske kisline

Country Status (13)

Country Link
EP (1) EP0789707A4 (zh)
JP (1) JPH10508312A (zh)
KR (1) KR100393336B1 (zh)
CN (1) CN1171112A (zh)
AU (1) AU693622B2 (zh)
CA (1) CA2202274A1 (zh)
HU (1) HU218086B (zh)
MX (1) MX9703188A (zh)
PL (1) PL185852B1 (zh)
RU (1) RU2154638C2 (zh)
SI (1) SI9520112A (zh)
UA (1) UA48150C2 (zh)
WO (1) WO1996014330A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840879A (en) * 1996-12-06 1998-11-24 Wang; Edge R. Reagents and solid supports for improved synthesis and labeling of polynucleotides
JP4594588B2 (ja) * 2001-04-10 2010-12-08 ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニヴァーシティ 抗体特異的プロファイルの治療的および診断的使用方法
CN101861318A (zh) * 2007-11-15 2010-10-13 Avi生物制药公司 合成吗啉代低聚物的方法
US8865898B2 (en) 2010-11-30 2014-10-21 Japan Science And Technology Agency Nucleoside analog or salt thereof, oligonucleotide analog, gene expression inhibitor, and nucleic-acid probe for detecting gene
RU2460721C1 (ru) * 2011-02-25 2012-09-10 Учреждение Российской академии наук Институт химической биологии и фундаментальной медицины Сибирского отделения РАН (ИХБФМ СО РАН) Способ получения амидофосфитного мономера ахиральной ненуклеотидной вставки для модификации олигонуклеотидов
DE102014007158A1 (de) * 2014-05-16 2015-11-19 Ugichem Gmbh Neue Peptid-Nukleinsäuren-Monomere und -Oligomere
MX2019014415A (es) 2017-06-16 2020-02-05 Eisai R&D Man Co Ltd Compuesto monomerico de acido nucleico modificado y analogo de acido oligonucleico.
CN113956183B (zh) * 2021-10-28 2023-06-20 成都市科隆化学品有限公司 一种Boc-Ser(Bzl)-OH及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2528107B2 (ja) * 1985-03-15 1996-08-28 サマ−トン,ジエ−ムス ポリヌクレオチド測定試薬と方法
DK51092D0 (da) * 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf

Also Published As

Publication number Publication date
PL185852B1 (pl) 2003-08-29
EP0789707A1 (en) 1997-08-20
HU218086B (hu) 2000-05-28
AU4234196A (en) 1996-05-31
WO1996014330A1 (en) 1996-05-17
AU693622B2 (en) 1998-07-02
RU2154638C2 (ru) 2000-08-20
MX9703188A (es) 1997-12-31
CA2202274A1 (en) 1996-05-17
PL320084A1 (en) 1997-09-15
UA48150C2 (uk) 2002-08-15
JPH10508312A (ja) 1998-08-18
HUT77435A (hu) 1998-04-28
EP0789707A4 (en) 1999-02-24
KR100393336B1 (ko) 2003-12-24
CN1171112A (zh) 1998-01-21
KR970707144A (ko) 1997-12-01

Similar Documents

Publication Publication Date Title
US5434257A (en) Binding compentent oligomers containing unsaturated 3',5' and 2',5' linkages
US6914148B2 (en) Guanidinium functionalized intermediates
EP0643720B1 (en) Binding competent oligomers containing 2', 5' linkages
JP3739785B2 (ja) 修飾されたピリミジンを含有するオリゴマーを使用する増強された三重らせんおよび二重らせんの成形
US6380368B1 (en) Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
US5830653A (en) Methods of using oligomers containing modified pyrimidines
US5955599A (en) Process for making oligonucleotides containing o- and s- methylphosphotriester internucleoside linkages
US6600032B1 (en) 2′-O-aminoethyloxyethyl-modified oligonucleotides
JP2002543215A (ja) A−dna型およびb−dna型立体配座幾何学形状を有するオリゴヌクレオチド
US5969135A (en) Oligonucleotide analogs with an amino acid or a modified amino alcohol residue
CA2256765A1 (en) 2'-substituted nucleosides and oligonucleotide derivatives
SI9520112A (sl) Aminokislinske nukleinske kisline
WO1993012135A1 (en) Nuclease stable and binding competent oligomers and methods for their use
CZ10042U1 (cs) Nukleosidy s modifikovaným cukrem
US6673912B1 (en) 2′-O-aminoethyloxyethyl-modified oligonucleotides